HIPK2 Cooperates with KRAS Signaling and Associates with Colorectal Cancer Progression.
Micol Di SegniIlaria VirdiaAlessandra VerdinaCarla Azzurra AmoreoSilvia BaldariGabriele ToiettaMaria Grazia DiodoroMarcella MottoleseIsabella SperdutiFabiola MorettiSimonetta BuglioniSilvia SodduGiuliana Di RoccoPublished in: Molecular cancer research : MCR (2022)
Our data indicate HIPK2 as a new player in the complex picture of the KRAS signaling network, providing rationales for future clinical studies and new treatment strategies for KRAS mutated colorectal cancer.